CMA Microdialysis, part of the Harvard Bioscience group, is a life science research tools company specializing in the development, manufacturing, and distribution of microdialysis products. Founded in 1984 in Sweden, CMA was the first company in the world to commercialize microdialysis technology. Today, it is a recognized global leader in the field, offering innovative tools for in vivo monitoring of organ and tissue chemistry.

The origins of microdialysis trace back to the early 1970s with Professor Urban Ungerstedt at the Karolinska Institute. Since then, the technique has become a standard in academic and pharmaceutical research, with over 13,000 scientific publications to date. CMA’s pioneering CMA 10 Microdialysis Probe revolutionized neurobiological studies and laid the groundwork for numerous other applications.

CMA's product range includes microdialysis probes, pumps, fraction collectors, and complete systems, all manufactured at its headquarters in Sweden under stringent quality controls, including clean room production for consumables. These tools are used worldwide in neuroscience, pharmacokinetics, and drug development to gather real-time data on unbound drug levels, metabolites, and endogenous compounds in tissues such as brain, liver, muscle, and synovial fluid.

The company remains committed to scientific excellence, working closely with researchers around the world to provide technical support, training, and ongoing development of advanced microdialysis solutions.